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Chronic renal failure (CRF) represents a world health problem. Ozone increases the endogenous antioxidant defense system, pre-
servingthecellredoxstate.Theaimofthisstudyistoevaluatetheeﬀectofozone/oxygenmixtureintherenalfunction,morphology,
and biochemical parameters, in an experimental model of CRF (subtotal nephrectomy). Ozone/oxygen mixture was applied daily,
by rectal insuﬄation (0.5mg/kg) for 15 sessions after the nephrectomy. Renal function was evaluated, as well as diﬀerent biochem-
ical parameters, at the beginning and at the end of the study (10 weeks). Renal plasmatic ﬂow (RPF), glomerular ﬁltration rate
(GFR), the urine excretion index, and the sodium and potassium excretions (as a measurement of tubular function) in the ozone
group were similar to those in Sham group. Nevertheless, nephrectomized rats without ozone (positive control group) showed
the lowest RPF, GFR, and urine excretion ﬁgures, as well as tubular function. Animals treated with ozone showed systolic arterial
pressure (SAP) ﬁgures lower than those in the positive control group, but higher values compared to Sham group. Serum creati-
nine values and protein excretion in 24 hours in the ozone group were decreased compared with nephrectomized rats, but were
still higher than normal values. Histological study demonstrated that animals treated with ozone showed less number of lesions in
comparison with nephrectomized rats. Thiobarbituric acid reactive substances were signiﬁcantly increased in nephrectomized and
ozone-treated nephrectomized rats in comparison with Sham group. In the positive control group, superoxide dismutase (SOD)
and catalase (CAT) showed the lowest ﬁgures in comparison with the other groups. However, ozone/oxygen mixture induced a
signiﬁcant stimulation in the enzymatic activity of CAT, SOD, and glutathione peroxidase, as well as reduced glutathione in relation
with Sham and positive control groups. In this animal model of CRF, ozone rectal administrations produced a delay in the advance
of the disease, protecting the kidneys against vascular, hemorheological, and oxidative mechanisms. This behavior suggests ozone
therapy has a protective eﬀect on renal tissue by downregulation of the oxidative stress shown in CRF.
INTRODUCTION
CRF represents a world health problem; once estab-
lished, it goes irreversibly to a ﬁnal stage, provoking the
patient death. In contrast with the capacity of the kidneys
to regain function following acute renal injury, renal in-
jury of a more prolonged nature often leads to progressive
andirreversibledestructionofnephronmass[1].Suchre-
duction of renal mass, in turn, causes structural and func-
tional hypertrophy of surviving nephrons. This compen-
satory hypertrophy is due to an adaptive hyperﬁltration
mediated by increase in glomerular capillary pressures
and ﬂows. Eventually, these adaptations prove maladap-
tive, predisposing to sclerosis of the residual glomerular
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population [1, 2, 3, 4]. The intrarenal vasculature is the
most aﬀected structure, preventing an appropriate blood
ﬂow, favoring the glomerular sclerosis [1, 2, 3, 4, 5]. For
that reason, the improvement of the rheological proper-
ties of the blood could delay the progression of the CRF.
Glomerulonephritis was the most common initiating
cause of CRF in the past, possibly because of its more
aggressive treatment. Now, diabetes mellitus and hyper-
tensive renal diseases are leading causes of CRF. The in-
exorable course to renal failure often is accompanied by
anemia, malnutrition, impaired metabolism of carbohy-
drates, fats, and proteins, impaired platelet function, and
defective utilization of energy [1].
Reactive oxygen species (ROS) play a key interme-
diary role in the pathophysiologic processes of a wide
variety of clinical and experimental renal diseases. It
ranges from acute to chronic injuries, making the kid-
ney the site in which several unrelated diseases involve
ROS [6] .R O Sh a v eb e e nd e m o n s t r a t e dt ob ec a p a b l eo f
degrading glomerular basement membrane and inducing222 Jos´ e Luis Calunga et al 2005:4 (2005)
glomerular injury, characterized by impaired glomerular
ﬁltration and sieving function [7, 8].
In order to eliminate toxic ROS, cells are equipped
with various antioxidant defense systems. Therefore,
the development of tissue injury depends on the bal-
ance between ROS generation and tissue antioxidant de-
fense mechanism [9]. Among various antioxidant sys-
tems equipped within aerobic cells, three antioxidant en-
zymes, superoxide dismutase (SOD), glutathione perox-
idase (GSH-Px), and catalase (CAT), are major mecha-
nisms to reduce local levels of ROS. Thus, these enzymes
distributed in cytosol and/or mitochondria can abase pri-
mary ROS, such as superoxide anion (by SOD) and hy-
drogen peroxide (by GSH-Px and CAT) before they can
interact to form more reactive cytotoxic metabolites (hy-
droxylradicalorhypochlorousacid,amongothers).Stud-
ies in the past demonstrated that glomerular antioxidant
enzymes levels are modulated. Thus, the glomerular an-
tioxidant enzymes are suggested to play an important role
in the functional derangement induced by the ROS [10].
CRF is associated with depressed SOD and elevated
NADPH oxidase expression, which can contribute to ox-
idative stress by increasing superoxide anion [11]. An-
other metabolic disturbance associated with CRF is hy-
perlipidemia, closely related with decreased removal and
increase of triacylglycerol production. Upregulation of
fatty acid synthase (FAS) gene expression reveals another
factor involved in disturbed lipid metabolism in CRF. It
seems that elevated plasma insulin and cytokine concen-
tration could play an important role in the mechanism
responsible for the increased FAS gene expression in CRF
[12].
Taking into account some of the ozone therapeutic
properties, suchas antiplatelet activity [13], enhancement
of cell energy [14], and the increase of the antioxidant de-
fense system [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], the
aim of this paper is to evaluate the eﬀect of ozone therapy
in the renal function, morphology, and biochemical pa-




All reagents used in determinations of GSH, SOD,
CAT, GSH-Px, and thiobarbituric acid reactive substances
(TBARS) were purchased from Sigma Chemicals (St
Louis, Mo). Other reagents of analytical grade were ob-
tained from normal commercial sources.
Animals
Thirty young female Wistar rats (180–200g)
were maintained in an air-ﬁltered and temperature-
conditioned room (20–22C) with a relative humidity of
50%–52%. Rats were fed with standard laboratory chow
and water ad libitum and were kept under an artiﬁcial
light/dark cycle of 12hours. The experiments were
performed in accordance with the ethical guidelines for
investigations in laboratory animals and were approved
by the Ethical Committee for Animal Experimentation
of the National Center for Scientiﬁc Research, Havana,
Cuba.
Treatmentscheduleandsurgicalprocedure
Ozone (O3) was generated by OZOMED 01 equip-
ment manufactured by the Ozone Research Center
(Cuba). Ozone was obtained from medical-grade oxygen
by means of a silent electric discharge, representing about
3%ofthegasmixture(ozone/oxygen).Theozoneconcen-
trationwasmeasuredbyusingaUVspectrophotometerat
254nm. The ozone dose is the product of the ozone con-
centration, expressed as mg/L, by the gas mixture volume
(L).Byknowingthebodyweightoftherat,theozonedose
is calculated as 0.5mg/kg.
Surgery was performed as previously described [26].
Ventral laparotomy was performed under aseptic condi-
tionsafteranesthesia(sodiumpentobarbital,30mg/kgin-
traperitoneal route). The right kidney was then removed,
while two-thirds of the left kidney underwent acute in-
farctionbyligationoftwoﬁrst-orderbranchesofthemain
renal artery. Recovery from anesthesia and from the sur-
g i c a lp r o c e d u r ew a sc o m p l e t ew i t h i n2 4h o u r s .
Animals were allocated randomly to 3 experimental
groups of 10 animals each: (1) Sham group (negative con-
trol group), where rats underwent a ventral laparotomy
under anesthesia as described above; however, only han-
dling of the renal pedicle without the removal of renal
mass was performed; (2) positive control group, where
rats were subjected to 5/6 renal ablation as described
above; and (3) ozone group, where rats were handled as
in group 2 but also received, after the damage, 15 ses-
sions of the gas mixture, composed of oxygen (O2)+O 3
(2.5−2.6mLataconcentrationof50µg/mL,representing
ad o s eo f0 .5mg/kg weight), by rectal insuﬄation, once
per day.
Samplepreparation
A day before the subtotal nephrectomy, all animals
werehousedinmetaboliccagesfor24hours,withoutfood
and water ad libitum. In all animals, the weight and the
systolic arterial pressure (SAP) in the tail, as well as pro-
tein excretion were measured. All these procedures and
measurements were repeated, after the partial nephrec-
tomy, once a week, for 10 weeks, the time during which,
the CRF continued its evolution. The time of the study
was not prolonged for more than 10 weeks, avoiding the
unpredictable death due to the ﬁnal stage of the CRF.
In the last day of evolution, plasmatic clearance of p-
aminohippurate (PAH) and inulin, in order to know the
renalplasmaﬂow(RPF)andtheglomerularﬁltrationrate
(GFR), respectively, were determined using the method
of unique injection (no urine) and the multicomparti-
mental analysis of the plasmatic concentration curves in 9
blood samples [27]. Also, the urine excretion index (urine2005:4 (2005) Ozone Therapy in Subtotal Nephrectomy Model 223
volume/wateringested)andsodiumandpotassiumexcre-
tions were determined in order to know tubular work.
Creatinine in serum was determined in the ﬁnal blood
sample obtained by intracardiac puncture (2mL of blood
were extracted). Thereafter the animals were euthanized
by ether anesthesia. The kidneys were dissected and im-
mediately frozen at −20C until analysis could be com-
pleted.
Biochemicalassays
PAH and inulin were determined in deproteinated
plasmasamplesbycadmiumsulfate,usingforPAHapho-
tocolorimetric technique, modiﬁed by Smith and Tinkel-
stein [28]. Inulin was measured by the direct method of
resorcinol without alkaline treatment [29]; correspond-
ing calibration curves were used [30]. Proteins were cal-
culated by the Biuret photocolorimetric technique us-
ing a Shimadzu spectrophotometer [31]. Potassium and
sodium urine concentrations were measured for the cal-
culation of the excretions of both substances in a Corn-
ing ﬂame photometer (model 400), using the method
described by Oser [32]. Creatinine in plasma was mea-
sured in deproteinated ﬁltrates by the method of sodium
tungstate, using for its evaluation the method of picric
acid modiﬁed by Brot [33].
Kidney homogenates were obtained using a tissue ho-
mogenator Ultra-Turrax T25 polytron at 4C. The ho-
mogenates were prepared by using a 100mM KCl buﬀer
(pH 7) containing EDTA 0.3mM (1:10w/v) for GSH,
TBARS, GSH-Px, and SOD determinations (buﬀer 1).
The homogenates were spun down with a centrifuge
at 600g for 60minutes at 4C. The supernatants were
taken for the biochemical determinations. GSH was de-
terminedbyaslightlymodiﬁedversionofBeutlermethod
[34], using a spectrophotometer. One mL of the kid-
ney homogenate, as described before, was mixed with
1.5mL of 5% metaphosphoric acid and centrifuged at
3000g for 10minutes at room temperature. Fifty hun-
dred microliters of this acidic supernatant was mixed
with 2mL of 0.2M phosphate buﬀer and 0.25mL of
0.04% 5,5 -dithio-bis-2-nitrobenzoic acid. Absorbance
of the yellow solution was measured at 412nm within
10minutes. A molar extinction coeﬃcient of 13.6Mcm
−1
that describes the formation of the thiolate anion by
the reaction of sulfhydryl groups with 5,5 -dithio-bis-2-
nitrobenzoicacid(DTNB)at412nmwasusedtoquantify
GSH.
Enzymatic activity of SOD was determined by a mod-
iﬁed version of Minami and Yoshikawa method [35]. One
unit of SOD enzymatic activity is equal to the amount
of enzyme that diminishes the initial absorbance of nitro
blue tetrazolium by 50%.
CAT was determined according to Evans and Diplock
method [36]. Kidney homogenates for CAT enzymatic
assay were carried out using 50mM phosphate buﬀer
(pH 7) containing 1% Triton X-100 (1:9w/v) (buﬀer
2). The enzyme activity is expressed as the ﬁrst-order
constant that describes the decomposition of H2O2 at
room temperature.
Enzymatic activity of GSH-Px was measured using a
modiﬁed version of Thonson et al method (see [37]). The
enzyme activity is expressed as international units of en-
zymatic activity/mg of protein. International units are ex-
pressed as µmol of hydroperoxides transformed/min/mL
of enzyme.
To estimate TBARS levels, a method described by
Ohkawa et al. [38] was used. The absorbance of 3mL of
the colored layer was measured spectrophotometrically at
532nm, using 1,1,3,3-tetraethoxypropane as a standard.
Protein concentrations were determined by the
method of Lowry [39], using bovine serum albumin as
a standard.
Histologicalstudy
Samples of rat kidneys were taken, ﬁxed in 10% neu-
tralbuﬀeredformalin,processed,andembeddedinparaf-
ﬁn. A pathologist unaware of the treatment schedule
examined the histological sections, stained with hema-
toxylin and eosin.
Statisticalanalysis
First, the outliers preliminary tests for detection of
error values were used. Afterward, the one-way analy-
sis of variance (ANOVA) then homogeneity variance test
(Bartlett-Box) were applied. In addition, Duncan’s multi-
ple range test and the Student t test, for the comparison
of two groups, were done. Results are presented as mean
± standard deviation (SD). Diﬀerent letters indicate a sta-
tistical signiﬁcance of at least P<. 05.
RESULTS
At the end of the study (10 weeks after the partial
nephrectomy), animals treated with ozone showed SAP
ﬁgures lower than those in the positive control group, but
higher values compared to those in Sham group (negative
controlgroup).Urineexcretionindex,intheozonegroup,
was similar to the negative control group; however, posi-
tivecontrolgroupshowedlowervaluescomparedtothose
in the other groups (Table 1). Compared to protein ex-
cretion and serum creatinine, ﬁgures, in the ozone group,
were higher than those in the negative control group, but
lower than those in the positive control group. Potas-
sium and sodium excretion values in negative control and
ozone groups weresimilar, butlowerinthe positive group
compared to negative and ozone groups (Table 1). RPF
and GFR in ozone and Sham groups showed similar ﬁg-
ures, but they are higher compared to those in positive
control group (Table 1).
Histological renal injuries (RI) were 0%, 13%, and
100% in the Sham, ozone, and positive control groups,
respectively (Table 2). The histological ﬁndings for ozone
and positive control groups were glomerular collapse
(GC), tubule degeneration (TD), and cortical-medullary224 Jos´ e Luis Calunga et al 2005:4 (2005)
Table 1. Behavior of the systolic arterial pressure (SAP); urine excretion index; protein, potassium, and sodium excretions; creatinine
ﬁgures; renal plasmatic ﬂow (RPF); and glomerular ﬁltration rate (GFR), at the end of the study, in the diﬀerent groups. Data are
mean ± SD. a, b,a n dc denote statistical signiﬁcance of at least P<. 05.
Measurements
Groups
Sham Positive control Ozone
SAP (mmHg) 111 ±13a 165 ±13b 130 ±13b
Urine excretion index 1.26 ±0.20a 0.82 ±0.14b 1.20 ±0.22a
Protein excretion (mg/24h/100g rat) 1.31 ±0.23a 8.78 ±2.06b 4.08 ±0.85c
Potassium excretion (mEq/24h/100g rat) 34.3 ±10.5a 26.2 ±8.3b 30.6 ±9.3a
Sodium excretion (mEq/24h/100g rat) 575 ±55a 440 ±60b 507 ±40a
Plasma creatinine (µmol/L) 95 ±15a 160 ±11b 106 ±10c
RPF (mL/min/100g rat) 1.71 ±0.25a 1.22 ±0.67b 1.85 ±0.22a
GFR (mL/min/100g rat) 0.34 ±0.01a 0.26 ±0.06b 0.36 ±0.02a
Table 2. Histological ﬁndings in the residual renal mass,
due to the partial nephrectomy, in the diﬀerent experimental
groups, where GCD stands for glomerular capsule dilatation;
GC glomerular collapse; CTD convoluted tubules dilatation;
TD tubule degeneration; CMH cortical-medullar hemorrhages;
and RI renal injury. ∗ denotes statistical signiﬁcance of at least
P<. 05
Groups GCD% GC% CTD% TD% CMH% RI%
Sham 0 0 0 0 0 0
Positive control 100 100 100 100 100 100
Ozone 100 20∗ 100 10∗ 10∗ 13∗
hemorrhages (CMH), with 100% for the positive control
group compared with 20%, 10%, and 10%, respectively,
fortheozonegroup.Convolutedtubulesdilatation(CTD)
and glomerular capsule dilatation (GCD) were similar for
these groups, shown in 100% of animals. The histological
study of renal cortex is observed in Figure 1.G C Da n d
CTD are reversible structural alterations that appear in
the ﬁrst stages of the renal damage by vascular ablation.
However, GC, TD, and CMH are lesions that have a sig-
niﬁcant eﬀect in the glomerular-tubular relation, causing
an irreversible damage in the renal function.
Subtotal nephrectomy induced a signiﬁcant increase
in TBARS (P = .0253) of 144%, whereas applications
of ozone/oxygen gaseous mixture after subtotal nephrec-
tomy increased TBARS to 90% (P = .0253) over the lev-
els of positive control group (Table 3). SOD activity was
signiﬁcantly decreased to 55% (P = .0143) in positive
control group, but, in ozone group, 39% of the enzy-
matic activity was recovered (P = .0253). Ozone ther-
apy after subtotal nephrectomy induced a total increase
in SOD activity of 94% (P = .0281). A similar behav-
ior was observed for CAT enzymatic activity. In positive
control group there was a signiﬁcant decrease of 50%,
whereas in ozone group a recovery of 218% was observed
(P = .0143) in the enzymatic activity of CAT, indicating a
total increase in CAT activity of 268% (P = .0034). GSH
concentration and GSH-Px enzymatic activity were not
signiﬁcantly aﬀected by subtotal nephrectomy in this an-
imal model, but when ﬁfteen intrarectal applications of
ozone/oxygen gaseous mixture were applied we observed
a signiﬁcant stimulation of GSH-Px, as well as an increase
in GSH concentration. Renal GSH concentration was sig-
niﬁcantly increased to 87% (P = .0253) whereas GSH-Px
activity was increased to 39% (P = .0253) (Table 3).
DISCUSSION
Animals submitted to the subtraction of 5/6 of the
total renal mass moved forward the installation of the
CRF, demonstrated by the decrease of RPF and GFR
and the increase of SAP, plasma creatinine, protein ex-
cretion, decrease of potassium and sodium excretions, as
well as the presence of renal damage in the histologi-
cal study. This behavior is still more pronounced in the
positive control group, where the renal damage reached
100%.
The results have shown, at the end of the study, that
the animals treated with ozone had the highest ﬁgures
o fR P Fa n dG F R ,a sw e l la sl o w e rﬁ g u r e so fp r o t e i n u r i a ,
plasma creatinine concentration, higher urine excretion,
and lower SAP in comparison with the positive control
group.Theseresultscanbelinkedtotheozoneantiplatelet
activity [10], diminishing blood viscosity, that could pro-
duce a decrease in the friction between the blood and
the glomerular vascular walls, decreasing the ﬂow resis-
tance, increasing the RPF and GFR, achieving similar ﬁg-
ures to those shown in the Sham group. The ﬂow rise
contributes to diminishing the endothelial injuries and
the glomerular collapse, avoiding the tubular hypoxia, the
hemorrhages, and the release of several proinﬂammatory
cytokines [40, 41, 42, 43].
A depression in SOD expression was reported previ-
ously [11] for the same CRF model that we used, that
could be correlated with the observed diminution in
the activity of SOD and CAT, which can contribute to2005:4 (2005) Ozone Therapy in Subtotal Nephrectomy Model 225
(a) (b) (c)
Figure 1. Histological study of the renal cortex. (a) Sham group (200×), normal morphology; (b) positive control group (200×),
glomerular collapse, cortical hemorrhages, vascular congestion, dilatation of convoluted tubules and glomerular capsule dilatation;
and (c) ozone group (400×), a discrete dilatation of convoluted tubules.
Table 3. Renal concentration of diﬀerent biochemical parameters, thiobarbituric acid reactive substances (TBARS), catalase (CAT),
superoxidedismutase(SOD),reducedglutathione(GSH),andglutathioneperoxidase(GPx),attheendofthestudyintheexperimen-
tal groups. One unit of SOD enzymatic activity is equal to the amount of enzyme that diminishes the initial absorbance of nitroblue
tetrazolium by 50% and CAT activity is described as the enzymatic activity quantity that transforms 1mol of H2O2,a tr o o mt e m p e r -
ature, at 15min/g of wet tissue. International units are expressed as µmol of transformed hydroperoxides/min/mL of GPx. a, b,a n dc
denote statistical signiﬁcance of at least P<. 05.
Biochemical parameters Groups
Sham Positive control Ozone
TBARS (nmol/mg protein) 0.25 ±0.03a 0.61 ±0.25b 1.16 ±0.32c
CAT (K15/g of wet tissue) 6.80 ±0.39a 3.40 ±0.41b 11.12 ± 2.47c
SOD (units/mg protein) 8.72 ±1.15a 4.74 ±0.22b 16.60 ± 0.29c
GSH (nmol/mg protein) 7.87 ±0.90a 7.84 ± 0.47a 14.29 ±1.20b
GPx (IU/mg protein) 6.01 ±0.25a 7.53 ± 0.94a 10.47 ±1.22b
oxidative stress by increasing superoxide anion and hy-
drogen peroxide generation.
As it was reported before [14, 15, 16, 17, 18, 19, 20, 21,
22,23,24], ozone therapy is anoxidative approach that by
provoking brief moments of oxidative stress, may stimu-
late antioxidant system to ﬁght against the phenomenon
per se. Thus, the signiﬁcant increase in lipid peroxida-
tion, measured in the form of TBARS, was expected af-
ter the surgical procedure, followed by ﬁfteen ozone ap-
plications. In spite of the signiﬁcant increase in TBARS,
an increase in antioxidant status was seen in the ozone
group. The increase in renal TBARS might not be re-
lated with an increase in renal damage because the re-
markable increase in antioxidant system surpasses this
eﬀect, inducing a general status of antioxidant protec-
tion.
Renal damage in this model of CRF might correspond
with generation of ROS, such as superoxide anion and hy-
drogen peroxide. Renal GSH concentration and GSH-Px
activitymightnotbedirectlyaﬀectedbysubtotalnephrec-
tomy in this model. However, ozone therapy induced a
signiﬁcant increase in renal GSH amount and GSH-Px
activity (P = .0253), besides a remarkable stimulation
of SOD and CAT activities, that surpass the increase in
lipid peroxidation. This suggests that ozone therapy has
ap r o t e c t i v ee ﬀect on renal tissue, by upregulation of the
antioxidant system, protecting against the oxidative stress
provoked by ischemia.
On the other hand, it had been demonstrated that
ozone is able to regulate the calcium levels, maintaining
its homeostasis, avoiding any damage to the cell structure
[44]. Also, it is possible that the ozone therapy eﬀect,
with the stimulation of the antioxidant defense system
[14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], protected
the tissues against the oxidative stress shown in CRF [6],
being in correspondence with the positive histological re-
sults obtained, where the ozone group showed the lowest
percent of glomerular collapse, tubule degeneration, and
cortical-medullary hemorrhages compared with positive
control group.
In conclusion, in this animal model of CRF, rectal ad-
ministrations of ozone produced a delay in the advance of
the disease, protecting the kidneys against the deleterious
eﬀects shown in the CRF. Consequently, whenever possi-
ble, ozone therapy may become an important therapy to
improve the quality of life of patients suﬀering CRF.226 Jos´ e Luis Calunga et al 2005:4 (2005)
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